NeuroOne Medical Technologies Corporation NMTC
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.33% | 72.45% | -11.65% | 2,008.30% | 105.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.33% | 72.45% | -11.65% | 2,008.30% | 105.39% |
| Cost of Revenue | 12.83% | 21.00% | 7.74% | 87.20% | 12.95% |
| Gross Profit | 9.41% | 75.46% | -76.40% | 450.67% | 70.67% |
| SG&A Expenses | 34.76% | -1.08% | -7.73% | -3.39% | -13.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.74% | 10.46% | 194.30% | 130.24% | -1.02% |
| Operating Income | -28.50% | 21.61% | -199.77% | 51.32% | 32.47% |
| Income Before Tax | -33.67% | 8.14% | -180.54% | 51.67% | 45.77% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -33.67% | 8.14% | -180.54% | 51.67% | 45.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.67% | 8.14% | -180.54% | 51.67% | 45.77% |
| EBIT | -28.50% | 21.61% | -199.77% | 51.32% | 32.47% |
| EBITDA | -30.62% | 21.94% | -192.43% | 52.53% | 33.35% |
| EPS Basic | -24.99% | 43.87% | -149.34% | 71.22% | 69.48% |
| Normalized Basic EPS | -23.84% | 52.29% | -168.00% | 90.77% | 62.97% |
| EPS Diluted | -44.95% | 43.18% | -151.81% | 71.22% | 68.70% |
| Normalized Diluted EPS | -22.78% | 52.29% | -168.08% | 90.77% | 62.97% |
| Average Basic Shares Outstanding | 6.93% | 63.64% | 63.21% | 67.93% | 77.69% |
| Average Diluted Shares Outstanding | 7.89% | 63.64% | 62.99% | 67.93% | 77.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |